Rachel di Mauro Dipm McIm

Rachel Di Mauro DipM MCIM has a wide range of work experience in marketing and sales. Rachel is currently the Head of Sales and Clinical Services EMEA at Gentherm Medical. Prior to that, they worked as a CIM Tutor and Assignment Support at Oxford College of Marketing. Rachel also had a long tenure at 3M, where they held various roles such as EMEA Marketing Manager, Global Campaign Lead, Business Development Manager, and Senior Marketing Executive. Rachel has extensive experience in strategic marketing, business development, and managing marketing campaigns. Rachel's earlier experience includes working as an International Marketing Executive at Arizant Healthcare and as a Marketing Manager at Single Use Surgical Ltd.

Rachel Di Mauro DipM MCIM began their education at Chaucer Community School in Sheffield from 1997 to 2002. During this time, they obtained a GNVQ and GSCE in various subjects, including German, Business Studies, English Language & Literature, Maths, Science, and Food Technology.

Rachel'seducation continued at King Edward VII School in Sheffield from 2002 to 2004, where they achieved an AVCE and A Level in Business Studies, German, and English.

Rachel then attended the University of Reading from 2004 to 2007 and earned a Bachelor of Arts (Honors) degree in Management and Business Administration.

In 2009, they pursued further education in marketing by enrolling at CIM | The Chartered Institute of Marketing. Rachel completed their Professional Diploma in Marketing from 2009 to 2010, advancing their knowledge and skills in the field.

To further enhance their expertise, Rachel attended the Oxford College of Marketing from 2012 to 2013. Here, they obtained a Chartered Post Graduate Diploma in Marketing at Level 7, consolidating their understanding and qualifications in the marketing field.

Rachel's commitment to professional growth is evident through their recent certification as a CIM Chartered Marketer MCIM Member, awarded by CIM | The Chartered Institute of Marketing in March 2021.